{
    "brief_title": "Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer",
    "phase": "Phase 2",
    "drugs": "['Endostar', 'Chemotherapy']",
    "drugs_list": [
        "Endostar",
        "Chemotherapy"
    ],
    "diseases": "['Breast Cancer']",
    "diseases_list": [
        "Breast Cancer"
    ],
    "enrollment": "50.0",
    "inclusion_criteria": "inclusion criteria: \n\n locoregionally Recurrent or metastatic breast cancer confirmed by histology. \n\n HER-2 Negative Breast Cancer. \n\n At least one measurable lesion according to RECIST 1.1.. \n\n Chemotherapy for recurrent and metastatic lesions should be discontinued for more than 2 weeks. \n\n 18-70 years old. \n\n ECOG PS 0\uff5e1. \n\n Participants must have normal organ and marrow function as defined below: ANC \u2265 1.5\u00d7109/L,PLT \u2265 75\u00d7109/L,Hb \u2265 100 g/L;TBIL\u22641.0ULN\uff1bALT and AST\u22643\u00d7ULN\uff08ALT and AST\u22645\u00d7ULN if liver metastasis\uff09;BUN and Cr\u22641.5\u00d7ULN and CCr\u226550 mL/min. \n\n life expectancy is not less than 12 weeks. \n\n Signed informed consent. \n\n ",
    "exclusion_criteria": ": \n\n Uncontrolled central nervous system metastasis. \n\n Not recovered to 0-1 degree (CTC AE 4.0) from toxic reactions of previous treatments.. \n\n History of allergy to biological agents in the past. \n\n Important organ dysfunction and severe heart disease, including congestive heart failure, uncontrollable arrhythmia, angina, valvular disease, myocardial infarction, and refractory hypertension. \n\n Pregnant or lactating women.. \n\n The patient had a history of other malignant tumors, except for the cured skin basal cell carcinoma and cervical cancer. \n\n The risk of uncontrolled infection, thrombosis and bleeding exists. \n\n A history of immunodeficiency, including HIV positive, HCV, active hepatitis B, or other acquired, congenital immunodeficiency disorders, or organ transplantation, is known. \n\n Researchers consider it inappropriate to carry out the study.",
    "brief_summary": "This research study is studying endostar in combination with chemotherapy as a possible treatment for HER-2 negative advanced breast cancer.",
    "NCT_ID": "NCT03907098"
}